GSK plc Reports Share Transaction
Ticker: GLAXF · Form: 6-K · Filed: Jul 14, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, sec-filing
TL;DR
GSK bought back its own shares, filing with SEC today.
AI Summary
GSK plc announced a transaction in its own shares on July 14, 2025. The company, formerly known as GlaxoSmithKline PLC, is reporting this transaction as part of its regular filings with the SEC.
Why It Matters
This filing indicates GSK is actively managing its share capital, which can impact shareholder value and financial metrics.
Risk Assessment
Risk Level: low — This is a routine filing about share transactions, not indicative of new risks.
Key Players & Entities
- GSK plc (company) — Registrant
- GlaxoSmithKline PLC (company) — Former company name
- 001-15170 (other) — SEC File Number
- 20250714 (date) — Filing Date
FAQ
What type of transaction did GSK plc report?
GSK plc reported a transaction in its own shares.
When was this transaction reported to the SEC?
The transaction was reported on July 14, 2025.
What is GSK plc's SEC file number?
GSK plc's SEC file number is 001-15170.
What was GSK plc formerly known as?
GSK plc was formerly known as GlaxoSmithKline PLC.
Is GSK plc required to file Form 20-F?
Yes, the filing indicates that GSK plc files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 14, 2025 regarding GSK plc (GLAXF).